Skip to content

Clinical application of inhaled rock salt aerosol therapy in patients with bronchiectasis

Clinical application of inhaled rock salt aerosol therapy in patients with bronchiectasis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103392
Enrollment
Unknown
Registered
2025-05-28
Start date
2024-07-24
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchiectasis

Interventions

experimental group:Inhalation of rock salt aerosol therapy
control group1:Other nebulizing treatments
Control group 2:No fogging is used

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The diagnosis is consistent with the Expert Consensus on the diagnosis and Treatment of Adult bronchiectasis in China; 2. At least 18 years old; 3. Meet the definition of acute exacerbation in BTS bronchiectasis guidelines; 4. Both communication and cognitive abilities are normal, and I am willing to cooperate with the completion of this experiment.

Exclusion criteria

Exclusion criteria: 1. Combined with major cardiopulmonary damage; 2. Combined with malignant tumor, the expected survival is short; 3. Combined immune deficiency.

Design outcomes

Primary

MeasureTime frame
Improvement of clinical symptoms;Indicators of sputum change;Immunological indicators and other biomarkers;Etiological results;

Secondary

MeasureTime frame
conventional inflammatory marks;iconography;lung function;Impaired health and quality of life;BSI score;

Countries

China

Contacts

Public ContactKong Jinliang

The First Affiliated Hospital of Guangxi Medical University

kjl071@163.com+86 139 7888 1546

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026